Peroxisome proliferator-activated receptor γ ligands and atherosclerosis:: ending the heartache

被引：54
作者：
Rosen, ED
Spiegelman, BM
机构：
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 106卷 / 05期
关键词：
D O I：
10.1172/JCI10909
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：629 / 631
页数：3
相关论文
共 32 条
[1]   Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene [J].
Arai, T ;
Wang, N ;
Bezouevski, M ;
Welch, C ;
Tall, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :2366-2371
[2]   PPARγ is required for placental, cardiac, and adipose tissue development [J].
Barak, Y ;
Nelson, MC ;
Ong, ES ;
Jones, YZ ;
Ruiz-Lozano, P ;
Chien, KR ;
Koder, A ;
Evans, RM .
MOLECULAR CELL, 1999, 4 (04) :585-595
[3]  
Berkowitz R, 1996, DIABETES, V45, P1572
[4]   A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat [J].
Brown, KK ;
Henke, BR ;
Blanchard, SG ;
Cobb, JE ;
Mook, R ;
Kaldor, I ;
Kliewer, SA ;
Lehmann, JM ;
Lenhard, JM ;
Harrington, WW ;
Novak, PJ ;
Faison, W ;
Binz, JG ;
Hashim, MA ;
Oliver, WO ;
Brown, HR ;
Parks, DJ ;
Plunket, KD ;
Tong, WQ ;
Menius, JA ;
Adkison, K ;
Noble, SA ;
Willson, TM .
DIABETES, 1999, 48 (07) :1415-1424
[5]   The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome [J].
Dunaif, A ;
Scott, D ;
Finegood, D ;
Quintana, B ;
Whitcomb, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3299-3306
[6]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[7]   Insulin resistance and cardiovascular disease [J].
Ginsberg, HN .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) :453-458
[8]  
GINSBERG HN, 1998, LANCET, V352, P837
[9]  
GINSBERG HN, 1998, LANCET, V354, P602
[10]   The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II [J].
Hattori, Y ;
Akimoto, K ;
Kasai, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (03) :1144-1149
1234